243 related articles for article (PubMed ID: 20966392)
1. In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.
Kashimura T; Briston SJ; Trafford AW; Napolitano C; Priori SG; Eisner DA; Venetucci LA
Circ Res; 2010 Dec; 107(12):1483-9. PubMed ID: 20966392
[TBL] [Abstract][Full Text] [Related]
2. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
3. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Neco P; Torrente AG; Mesirca P; Zorio E; Liu N; Priori SG; Napolitano C; Richard S; Benitah JP; Mangoni ME; Gómez AM
Circulation; 2012 Jul; 126(4):392-401. PubMed ID: 22711277
[TBL] [Abstract][Full Text] [Related]
5. R4496C RyR2 mutation impairs atrial and ventricular contractility.
Ferrantini C; Coppini R; Scellini B; Ferrara C; Pioner JM; Mazzoni L; Priori S; Cerbai E; Tesi C; Poggesi C
J Gen Physiol; 2016 Jan; 147(1):39-52. PubMed ID: 26666913
[TBL] [Abstract][Full Text] [Related]
6. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
Sung RJ; Lo CP; Hsiao PY; Tien HC
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1625-38. PubMed ID: 21742998
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.
Cerrone M; Colombi B; Santoro M; di Barletta MR; Scelsi M; Villani L; Napolitano C; Priori SG
Circ Res; 2005 May; 96(10):e77-82. PubMed ID: 15890976
[TBL] [Abstract][Full Text] [Related]
8. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
Liu N; Colombi B; Memmi M; Zissimopoulos S; Rizzi N; Negri S; Imbriani M; Napolitano C; Lai FA; Priori SG
Circ Res; 2006 Aug; 99(3):292-8. PubMed ID: 16825580
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
[TBL] [Abstract][Full Text] [Related]
10. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
[TBL] [Abstract][Full Text] [Related]
11. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
12. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.
Sedej S; Schmidt A; Denegri M; Walther S; Matovina M; Arnstein G; Gutschi EM; Windhager I; Ljubojević S; Negri S; Heinzel FR; Bisping E; Vos MA; Napolitano C; Priori SG; Kockskämper J; Pieske B
J Am Coll Cardiol; 2014 Apr; 63(15):1569-79. PubMed ID: 24315909
[TBL] [Abstract][Full Text] [Related]
13. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Bai Y; Jones PP; Guo J; Zhong X; Clark RB; Zhou Q; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Semeniuk L; Guo A; Song LS; Duff HJ; Chen SR
Circ Res; 2013 Aug; 113(5):517-26. PubMed ID: 23856523
[TBL] [Abstract][Full Text] [Related]
14. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
15. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required.
Venetucci LA; Trafford AW; Eisner DA
Circ Res; 2007 Jan; 100(1):105-11. PubMed ID: 17110597
[TBL] [Abstract][Full Text] [Related]
16. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
Kujala K; Paavola J; Lahti A; Larsson K; Pekkanen-Mattila M; Viitasalo M; Lahtinen AM; Toivonen L; Kontula K; Swan H; Laine M; Silvennoinen O; Aalto-Setälä K
PLoS One; 2012; 7(9):e44660. PubMed ID: 22962621
[TBL] [Abstract][Full Text] [Related]
17. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
Bovo E; Mazurek SR; Zima AV
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
[TBL] [Abstract][Full Text] [Related]
18. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
[TBL] [Abstract][Full Text] [Related]
19. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.
Herron TJ; Milstein ML; Anumonwo J; Priori SG; Jalife J
Heart Rhythm; 2010 Aug; 7(8):1122-8. PubMed ID: 20538074
[TBL] [Abstract][Full Text] [Related]
20. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.
Hilliard FA; Steele DS; Laver D; Yang Z; Le Marchand SJ; Chopra N; Piston DW; Huke S; Knollmann BC
J Mol Cell Cardiol; 2010 Feb; 48(2):293-301. PubMed ID: 19835880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
